A study of the probit model with latent variables in Phase I clinical trials (Q5220814): Difference between revisions

@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / full work available at URL @@
+https://doi.org/10.1080/00949655.2014.885976
+Normal rank
@@ Property / OpenAlex ID @@
+W1990315220
@@ Property / OpenAlex ID: W1990315220 / rank @@
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Operating characteristics of the standard phase I clinical trial design.
+Normal rank
@@ Property / cites work @@
+Consistency of continual reassessment method under model misspecification
+Normal rank
@@ Property / cites work @@
+Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
+Normal rank
@@ Property / cites work @@
+Two-dimensional toxic dose and multivariate logistic regression, with application to decompression sickness
+Normal rank
@@ Property / cites work @@
+On the multivariate predictive distribution of multi-dimensional effective dose: a Bayesian approach
+Normal rank
@@ Property / cites work @@
+Bayesian analysis of dichotomous quantal response models
+Normal rank
@@ Property / cites work @@
+Bayesian Analysis of Binary and Polychotomous Response Data
+Normal rank
@@ Property / cites work @@
+Sampling-Based Approaches to Calculating Marginal Densities
+Normal rank
@@ Property / cites work @@
+A phase I dose-finding study based on polychotomous toxicity responses
+Normal rank